Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
Earnings Data
Report Date
Mar 12, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.04Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
BioLife Solutions demonstrated solid revenue growth and improved profitability, with strategic moves like the sale of the evo Cold Chain product line strengthening their financial position. However, challenges such as a decline in adjusted gross margin and increased operating expenses were noted. The overall sentiment is positive due to the strong growth metrics and strategic focus on core competencies.Company Guidance
Strong Revenue Growth
Cell processing revenue increased 33% year-over-year, contributing to a 31% increase in total revenue for the quarter. This growth reflects sustained strength across the biopreservation media franchise and broader cell processing portfolio.
Improved Profitability
Adjusted EBITDA margin expanded 500 basis points year-over-year to 28%, demonstrating the operating leverage inherent in the business model.
Sale of evo Cold Chain Product Line
The sale of the evo Cold Chain logistics product line for approximately $25 million in cash further strengthens the balance sheet, bringing cash and marketable securities to approximately $125 million.
Increased Guidance
Full year cell processing revenue guidance raised from $91 million-$93 million to $93 million-$94 million, representing a 26% to 28% year-over-year growth rate.
Market Leadership
BioLife's BPM products are embedded in 16 approved therapies and utilized in more than 250 commercially sponsored CGT clinical trials in the U.S., representing over a 70% share. Notably, this includes more than 30 Phase III trials where their share is nearly 80%.
BLFS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BLFS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $27.02 | ― | ― |
Aug 07, 2025 | $20.64 | $22.68 | +9.88% |
May 08, 2025 | $22.36 | $23.29 | +4.16% |
Mar 03, 2025 | $24.00 | $24.51 | +2.13% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BioLife Solutions (BLFS) report earnings?
BioLife Solutions (BLFS) is schdueled to report earning on Mar 12, 2026, Before Open (Confirmed).
What is BioLife Solutions (BLFS) earnings time?
BioLife Solutions (BLFS) earnings time is at Mar 12, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BLFS EPS forecast?
BLFS EPS forecast for the fiscal quarter 2025 (Q4) is >-0.01.